Diclofenac gel (topical)
Topical NSAID for a specific joint or muscle. Systemic exposure is a fraction of oral, which is the point.
Medications & hormones
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Diclofenac gel (topical)
Topical NSAID for a specific joint or muscle. Systemic exposure is a fraction of oral, which is the point.
Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.
Regulatory statement in source: FDA-approved.
Topical diclofenac is an NSAID applied to the skin. The linked FDA label covers diclofenac sodium topical solution 2%, approved for the pain of osteoarthritis of the knee, with initial US approval in 1988. It carries a boxed warning for serious cardiovascular and gastrointestinal events, as oral NSAIDs do. The label does not cover other joints or an over-the-counter gel.
Benefits reported in the imported source
- A topical solution for the pain of osteoarthritis of the knee.
- First approved in the United States in 1988, so the profile is long established.
Risks and limits
- Boxed warning for serious cardiovascular and gastrointestinal events, as with oral NSAIDs.
- The label does not cover joints other than the knee, or an over-the-counter gel.
Source bottom line: Topical diclofenac is FDA-approved for knee osteoarthritis pain and carries a boxed heart and gut warning.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
adults with arthritis pain of the hand, wrist, elbow, foot, ankle or knee, per the US over-the-counter label
- Reported regimen
- 2 g applied to each affected hand, wrist or elbow, or 4 g to each affected foot, ankle or knee, four times a day; no more than 16 g a day on any one joint
- Duration
- the label directs stopping at 21 days unless a doctor says otherwise
- Reported outcome
- The label carries this regimen for temporary relief of arthritis pain.
- Source
- Diclofenac sodium topical gel 1% drug facts (DailyMed)
Claim provenance
evidence.json#/catalog:medication:diclofenac-topical/protocols/0
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Historical research outcome: no-verified-description · 2026-10-06
No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere. The excerpt describes UK prescription status and available forms, not a reported community routine.
- https://www.nhs.uk/medicines/diclofenac/about-diclofenac/: no-practice-description — The excerpt describes UK prescription status and available forms, not a reported community routine.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
- Diclofenac Sodium topical gel FDA label
- Diclofenac sodium topical gel 1% drug facts (DailyMed)
- DailyMed: diclofenac topical
Snapshot provenance
Source ID: catalog:medication:diclofenac-topical. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.